Release Date: August 29, 2025
Expiration Date: August 29, 2026
Activity Overview
Recent practice-changing trial data are poised to change the management of extensive-stage small cell lung cancer (ES-SCLC) substantially. However, new treatment approaches are associated with novel challenges in managing adverse events, which may jeopardize treatment outcomes.
This podcast features a discussion about the appropriate management of adverse events described in recent pivotal trials for regimens used in ES-SCLC management. Led by Rohit Gosain, MD; and Rahul Gosain, MD; this session features a faculty expert in evaluating and treating SCLC.
Target Audience
This educational activity is directed toward medical oncologists, nurse practitioners, physician assistants, and oncology nurses who manage patients with SCLC.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Integrate evolving clinical trial data into patient-centered treatment plans for ES-SCLC
- Identify treatment-related toxicities associated with emerging therapies in SCLC
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here